319 related articles for article (PubMed ID: 12446175)
1. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.
Vernet D; Ferrini MG; Valente EG; Magee TR; Bou-Gharios G; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2002 Dec; 7(4):262-76. PubMed ID: 12446175
[TBL] [Abstract][Full Text] [Related]
2. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
3. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease.
Davila HH; Ferrini MG; Rajfer J; Gonzalez-Cadavid NF
BJU Int; 2003 Jun; 91(9):830-8. PubMed ID: 12780843
[TBL] [Abstract][Full Text] [Related]
4. Profibrotic role of myostatin in Peyronie's disease.
Cantini LP; Ferrini MG; Vernet D; Magee TR; Qian A; Gelfand RA; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2008 Jul; 5(7):1607-22. PubMed ID: 18422491
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic role of inducible nitric oxide synthase.
Ferrini MG; Vernet D; Magee TR; Shahed A; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2002 May; 6(3):283-94. PubMed ID: 12009846
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.
Davila HH; Magee TR; Vernet D; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2004 Nov; 71(5):1568-77. PubMed ID: 15240426
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.
Gelfand RA; Vernet D; Kovanecz I; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2015 Feb; 12(2):313-27. PubMed ID: 25496134
[TBL] [Abstract][Full Text] [Related]
8. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease.
Vernet D; Nolazco G; Cantini L; Magee TR; Qian A; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2005 Dec; 73(6):1199-210. PubMed ID: 16093362
[TBL] [Abstract][Full Text] [Related]
9. Experimental models of Peyronie's disease. Implications for new therapies.
Gonzalez-Cadavid NF; Rajfer J
J Sex Med; 2009 Feb; 6(2):303-13. PubMed ID: 19138365
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie's Disease.
Mateus M; Ilg MM; Stebbeds WJ; Christopher N; Muneer A; Ralph DJ; Cellek S
J Sex Med; 2018 Jul; 15(7):947-957. PubMed ID: 29891411
[TBL] [Abstract][Full Text] [Related]
11. The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes.
Ferrini MG; Rivera S; Moon J; Vernet D; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2010 Sep; 7(9):3033-44. PubMed ID: 20626593
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.
Bivalacqua TJ; Champion HC; Leungwattanakij S; Yang DY; Hyun JS; Abdel-Mageed AB; Sikka SC; Kadowitz PJ; Hellstrom WJ
J Androl; 2001; 22(3):497-506. PubMed ID: 11330651
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of penile fibrosis.
Gonzalez-Cadavid NF
J Sex Med; 2009 Mar; 6 Suppl 3():353-62. PubMed ID: 19267860
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models.
Ilg MM; Mateus M; Stebbeds WJ; Milenkovic U; Christopher N; Muneer A; Albersen M; Ralph DJ; Cellek S
Eur Urol; 2019 Feb; 75(2):329-340. PubMed ID: 30344087
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.
Ferrini MG; Kovanecz I; Nolazco G; Rajfer J; Gonzalez-Cadavid NF
BJU Int; 2006 Mar; 97(3):625-33. PubMed ID: 16469038
[TBL] [Abstract][Full Text] [Related]
16. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.
Bivalacqua TJ; Diner EK; Novak TE; Vohra Y; Sikka SC; Champion HC; Kadowitz PJ; Hellstrom WJ
J Urol; 2000 Jun; 163(6):1992-8. PubMed ID: 10799245
[TBL] [Abstract][Full Text] [Related]
17. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in Peyronie's disease.
Gonzalez-Cadavid NF; Magee TR; Ferrini M; Qian A; Vernet D; Rajfer J
Int J Impot Res; 2002 Oct; 14(5):361-74. PubMed ID: 12454687
[TBL] [Abstract][Full Text] [Related]
19. Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.
Zorba OU; Sirma S; Ozgon G; Salabas E; Ozbek U; Kadioglu A
Adv Clin Exp Med; 2012; 21(5):607-14. PubMed ID: 23356197
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.
Gonzalez-Cadavid NF; Rajfer J
Nat Rev Urol; 2010 Apr; 7(4):215-21. PubMed ID: 20212516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]